Lung cancer in Brazil: epidemiology and treatment challenges

Vanessa Karen de Sá,1,2 Juliano C Coelho,3 Vera Luiza Capelozzi,1 Sergio Jobim de Azevedo3 1Department of Pathology, Faculty of Medicine, University of São Paulo, 2Department of Genomics and Molecular Biology, International Research Center, A.C. Camargo Cancer Center, S&ati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: de Sá VK, Coelho JC, Capelozzi VL, Azevedo SJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/2c9f0cc8277f4f3f8fd06fd30175f387
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2c9f0cc8277f4f3f8fd06fd30175f387
record_format dspace
spelling oai:doaj.org-article:2c9f0cc8277f4f3f8fd06fd30175f3872021-12-02T03:00:18ZLung cancer in Brazil: epidemiology and treatment challenges1179-2728https://doaj.org/article/2c9f0cc8277f4f3f8fd06fd30175f3872016-11-01T00:00:00Zhttps://www.dovepress.com/lung-cancer-in-brazil-epidemiology-and-treatment-challenges-peer-reviewed-article-LCTThttps://doaj.org/toc/1179-2728Vanessa Karen de Sá,1,2 Juliano C Coelho,3 Vera Luiza Capelozzi,1 Sergio Jobim de Azevedo3 1Department of Pathology, Faculty of Medicine, University of São Paulo, 2Department of Genomics and Molecular Biology, International Research Center, A.C. Camargo Cancer Center, São Paulo, 3Department of Oncology, Clinical Research – UPCO, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil Abstract: Lung cancer persists throughout the world as a major cause of death. In 2014, data from the Brazilian National Cancer Institute (INCA) estimated 16.400 new cases of lung cancer among men (second most common) and 10.930 new cases among women (fourth most common). These data are consistent for all Brazilian regions and reflect the trends of cancer in the country over the last decade. Brazil is a continental country, the largest in Latin America and fifth in the world, with an estimated population of >200 million. Although the discrepancy in the national income between rich and poor has diminished in the last 2 decades, it is still huge. More than 75% of the Brazilian population do not have private health insurance and rely on the national health care system, where differences in standard of cancer care are evident. It is possible to point out differences from the recommendations of international guidelines in every step of the lung cancer care, from the diagnosis to the treatment of advanced disease. This review aims to describe and recognize these differences as a way to offer a real discussion for future modifications and action points toward delivery of better oncology care in our country. Keywords: NSCLC, screening, drivers mutations, diagnosis, Brazilian scenariode Sá VKCoelho JCCapelozzi VLAzevedo SJDove Medical PressarticleLung CancerEpidemiologyBrazilian populationScreeningtreatment.Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENLung Cancer: Targets and Therapy, Vol Volume 7, Pp 141-148 (2016)
institution DOAJ
collection DOAJ
language EN
topic Lung Cancer
Epidemiology
Brazilian population
Screening
treatment.
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Lung Cancer
Epidemiology
Brazilian population
Screening
treatment.
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
de Sá VK
Coelho JC
Capelozzi VL
Azevedo SJ
Lung cancer in Brazil: epidemiology and treatment challenges
description Vanessa Karen de Sá,1,2 Juliano C Coelho,3 Vera Luiza Capelozzi,1 Sergio Jobim de Azevedo3 1Department of Pathology, Faculty of Medicine, University of São Paulo, 2Department of Genomics and Molecular Biology, International Research Center, A.C. Camargo Cancer Center, São Paulo, 3Department of Oncology, Clinical Research – UPCO, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil Abstract: Lung cancer persists throughout the world as a major cause of death. In 2014, data from the Brazilian National Cancer Institute (INCA) estimated 16.400 new cases of lung cancer among men (second most common) and 10.930 new cases among women (fourth most common). These data are consistent for all Brazilian regions and reflect the trends of cancer in the country over the last decade. Brazil is a continental country, the largest in Latin America and fifth in the world, with an estimated population of >200 million. Although the discrepancy in the national income between rich and poor has diminished in the last 2 decades, it is still huge. More than 75% of the Brazilian population do not have private health insurance and rely on the national health care system, where differences in standard of cancer care are evident. It is possible to point out differences from the recommendations of international guidelines in every step of the lung cancer care, from the diagnosis to the treatment of advanced disease. This review aims to describe and recognize these differences as a way to offer a real discussion for future modifications and action points toward delivery of better oncology care in our country. Keywords: NSCLC, screening, drivers mutations, diagnosis, Brazilian scenario
format article
author de Sá VK
Coelho JC
Capelozzi VL
Azevedo SJ
author_facet de Sá VK
Coelho JC
Capelozzi VL
Azevedo SJ
author_sort de Sá VK
title Lung cancer in Brazil: epidemiology and treatment challenges
title_short Lung cancer in Brazil: epidemiology and treatment challenges
title_full Lung cancer in Brazil: epidemiology and treatment challenges
title_fullStr Lung cancer in Brazil: epidemiology and treatment challenges
title_full_unstemmed Lung cancer in Brazil: epidemiology and treatment challenges
title_sort lung cancer in brazil: epidemiology and treatment challenges
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/2c9f0cc8277f4f3f8fd06fd30175f387
work_keys_str_mv AT desavk lungcancerinbrazilepidemiologyandtreatmentchallenges
AT coelhojc lungcancerinbrazilepidemiologyandtreatmentchallenges
AT capelozzivl lungcancerinbrazilepidemiologyandtreatmentchallenges
AT azevedosj lungcancerinbrazilepidemiologyandtreatmentchallenges
_version_ 1718401972227276800